ErbB Inhibitory Protein [EBIP]: A Modified Ectodomain of EGFR Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells

Many solid tumors including breast cancer show increased activation of several growth factor receptors, specifically EGFR and its family members (EGFRs) as well as c-Src, a non-receptor tyrosine kinase that promote proliferation, inhibit apoptosis and induce metastasis. We hypothesize that inhibitio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nautiyal, Jyoti, Yu, Yingjie, Aboukameel, Amro, Kanwar, Shailender, Das, Jayanta K, Du, Jianhua, Patel, Bhaumik, Sarkar, Fazlul H., Rishi, Arun K., Mohammad, Ramzi, Majumdar, Adhip P. N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2884079/
https://ncbi.nlm.nih.gov/pubmed/20515951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados